Start date: 29 Jun 2016
End date: 02 Jul 2016
Location: Barcelona, Spain

The ESMO World Congress on Gastrointestinal Cancer is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours.

Press Releases

14.07.2016 The Debate on the Phase 3 Trial of MABp1 Presented at the 18th ESMO World Congress of Gastrointestinal Cancer
02.07.2016 Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly Over Placebo
30.06.2016 Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer
30.06.2016 Chemoradiotherapy After Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy
29.06.2016 Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition

Abstracts

View the Abstracts Supplement on Annals of Oncology

Important deadlines

Deadline	Date
Abstract deadline	14 March 2016
Early registration discount deadline	before 28 April 2016
Discounted registration deadline	28 April – 9 June 2016

Conference Officers & Scientific Committee

Chairs: Mario Dicato, Luxembourg; Eric Van Cutsem, Leuven, Belgium
Vice Chair: Josep Tabernero, Barcelona, Spain

Venue

The International Convention Center of Barcelona (CCIB)
Rambla de Prim 1-17
08019 Barcelona, Spain